OPNT - Opiant Pharmaceuticals misses by $0.24 misses on revenue March, 21 2019 04:07 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (NASDAQ:OPNT): Q4 GAAP EPS of -$0.37 misses by $0.24.Revenue of $4.76M (-59.5% Y/Y) misses by $0.39M.Press ReleaseMore news on: Opiant Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,